TY - JOUR
T1 - Novel COL4A1 mutations identified in infants with congenital hemolytic anemia in association with brain malformations
AU - Ogura, Hiromi
AU - Ohga, Shouichi
AU - Aoki, Takako
AU - Utsugisawa, Taiju
AU - Takahashi, Hidehiro
AU - Iwai, Asayuki
AU - Watanabe, Kenichiro
AU - Okuno, Yusuke
AU - Yoshida, Kenichi
AU - Ogawa, Seishi
AU - Miyano, Satoru
AU - Kojima, Seiji
AU - Yamamoto, Toshiyuki
AU - Yamamoto-Shimojima, Keiko
AU - Kanno, Hitoshi
N1 - Funding Information:
We would like to express our gratitude to the patients and their parents for their cooperation. This work was supported by the Japan Agency for Medical Research and Development (AMED); the Project for Development of Innovative Research on Cancer Therapeutics (JP19cm0106501 to S.O.) and the Practical Research Project for Rare/Intractable Diseases (JP 19ek0109286h0003 to S.O.); the Ministry of Education, Culture, Sports, Science and Technology of Japan; the High Performance Computing Infrastructure System Research Project (hp160219, hp170227, hp180198, and hp190158 to S.O.) (this research used computational resources of the K computer provided by the RIKEN Advanced Institute for Computational Science through the HPCI System Research project); and JSPS KAKENHI (JP16K10041 to H.K.).
PY - 2020/12
Y1 - 2020/12
N2 - Genetic causes of undiagnosed hemolytic anemia in nineteen patients were analyzed by whole-exome sequencing, and novel COL4A1 variants were identified in four patients (21%). All patients were complicated with congenital malformations of the brain, such as porencephaly or schizencephaly. In these patients, hemolysis became less severe within 2 months after birth, and red cell transfusion was no longer required after 50 days, whereas chronic hemolysis continued.
AB - Genetic causes of undiagnosed hemolytic anemia in nineteen patients were analyzed by whole-exome sequencing, and novel COL4A1 variants were identified in four patients (21%). All patients were complicated with congenital malformations of the brain, such as porencephaly or schizencephaly. In these patients, hemolysis became less severe within 2 months after birth, and red cell transfusion was no longer required after 50 days, whereas chronic hemolysis continued.
UR - http://www.scopus.com/inward/record.url?scp=85096756727&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096756727&partnerID=8YFLogxK
U2 - 10.1038/s41439-020-00130-w
DO - 10.1038/s41439-020-00130-w
M3 - Article
AN - SCOPUS:85096756727
VL - 7
JO - Human Genome Variation
JF - Human Genome Variation
SN - 2054-345X
IS - 1
M1 - 42
ER -